Colon polyp Follow-Up: 6 months vs 12 months – which is better?
NCT ID NCT07198945
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a 6-month or 12-month follow-up colonoscopy is better for people who had a large colon polyp (20-50 mm) removed that was not cancerous. About 546 adults will be assigned to one of the two follow-up schedules. The goal is to see which timing finds any returning polyp tissue more effectively and how easy it is to treat.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 546 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2026
- Expected to finish
-
Feb 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Patient Criteria 1. ≥ 18 years of age 2. Ability to provide informed consent 3. Willing and able to complete one electronic survey 4. Presenting for colonoscopy for any indication 5. Ability to understand the requirements of the study and agree to abide by the study restrictions and to return for the required assessments. Polyp Criteria 6. Size 20-50 mm as documented with photo containing open snare of known size as comparison. 7. Histology without high grade dysplasia: 1. Conventional Adenoma: adenoma with or without villous components 2. Serrated: hyperplastic or sessile serrated lesion Exclusion Criteria: Patient Criteria 1. Patients with confirmed diagnosis of inflammatory bowel disease, including Ulcerative Colitis and Crohn's Disease. 2. Patients with a known or suspected diagnosis of any of the following polyposis or non-polyposis syndromes with known genetic mutations: * Familial Adenomatous Polyposis Syndrome * MUTYH associated Polyposis Syndrome * Juvenile Polyposis Syndrome * Cowden's Syndrome * Peutz-Jeghers Syndrome * Hereditary Non-Polyposis Colorectal Cancer Syndrome (HNPCC) or Lynch Syndrome 3. Patients who have high grade dysplasia found in any polyp ≥ 20 mm removed at the index colonoscopy 4. Patients who have any colorectal cancer by histologic diagnosis at index procedure 5. Patients needing a colonoscopy 6 months or sooner for any indication following the index procedure including burden of synchronous disease, inadequate prep to assess for synchronous disease, inadequate prep that precludes resection of index large polyp, or other reason limiting ability to complete full examination of colon at time of resection. 6. ASA ≥ 4 or documented coagulopathy or severe thrombocytopenia (INR ≥ 2 or platelets ≤ 20). 7. Patients who have more than three ≥ 20mm polyps removed during the index colonoscopy 8. Patients with significant acute or chronic medical, neurologic, or illness that, in the judgment of the Principal Investigator, could compromise subject safety, limit the ability to complete the study, and/or compromise the objectives of the study. Polyp Criteria 9. Polyp located at appendiceal orifice, ileocecal valve, or intradiverticulum 10. Pedunculated or semi-pedunculated polyps (as defined by Paris Classification type Ip or Isp) 11. A polyp that is classified as a traditional serrated adenoma. 12. Polyps with features of invasive cancer 13. Polyps that are not able to be removed with standard endoscopic techniques for any reason 14. Polyps that are incompletely resected endoscopically at index procedure 15. Polyps removed by endoscopic submucosal dissection (ESD) or by full thickness resection device (FTRD)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Adenoma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
10 sites in 3 countries. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
Henry Ford Hospital
Detroit, Michigan, 48208, United States
-
Indiana University
Indianapolis, Indiana, 46202, United States
-
Rush University
Chicago, Illinois, 60612, United States
-
The University of Kansas Medical Center
Kansas City, Kansas, 66221, United States
-
University Medical Centre Ljubljana
Ljubljana, 1000, Slovenia
-
University of Alabama at Birmingham
Birmingham, Alabama, 35244, United States
-
University of British Columbia
Vancouver, British Columbia, V5Z 1M9, Canada
-
University of Colorado
Aurora, Colorado, 80045, United States
-
White River Junction VA Medical Center
White River Junction, Vermont, 05009, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria may hold clues to dozens of diseases
- Can MRI and computer models predict how well cancer drugs reach tumors?
- Can a personalized menu keep cancer patients stronger through chemotherapy?
- Can surgeons spare nerves and still cure colon cancer?
- The gatekeepers of tumors: scientists probe how blood vessels let immune cells in
- Blood test could guide stronger chemo for colon cancer